2023 Virtual Series:
Psychiatry in the 21st Century: Where Might the Future Take Us?
Join us as we explore advances in modern psychiatric treatments straight from the experts. Expect to hear about a range of topics from interventional psychiatry updates and the new TAAR1 receptor to updates on the current state of cannabis and psychedelic research.
This is a 4-part series with sessions falling on the last Thursday of the month between January and April 2023. Sessions will run from 6:30-8 p.m.
Upcoming Sessions:
Addressing Cannabis Use in a Changing Legal Landscape
April 27
Guest Speaker: Jesse D. Hinckley, MD, PhD
We will discuss the impact of cannabis legalization, including product availability, potency, and modes of use; perception of harm; and prevalence of use among adolescents and adults. Considering ongoing neurodevelopment, we will review the impact of cannabis use in adolescents and young adults. We will then explore the potential impact of cannabis use on comorbid mental health conditions. Finally, we will discuss how to discuss cannabis use with patients and evidence-based treatments for cannabis use disorder.
Dr. Jesse Hinckley graduated magna cum laude with his bachelor of science in neuroscience from Brigham Young University in 2005. After a short stent as a data analyst for the Combined DNA Index System (CODIS) at Myriad Genetics, he matriculated into the Medical Scientist Training Program at the University of Iowa. Dr. Hinckley transferred to the University of Colorado School of Medicine in 2008, and he graduated with his MD and PhD in Human Medical Genetics and Genomics in 2015. Upon graduation, Dr. Hinckley remained at the University of Colorado, where he completed his general psychiatry residency and child and adolescent psychiatry fellowship. Dr. Hinckley joined the faculty at the University of Colorado thereafter. He is an assistant professor in the Division of Addiction Research, Treatment & Prevention within the Department of Psychiatry. Dr. Hinckley currently serves as the Director of Adolescent Psychiatric Services for the Addiction Research and Treatment Services program and Associate Medical Director of psychiatric emergency services at UCHealth. He is co-founder and co-director of the Addiction Biology Lab at the University. Dr. Hinckley’s primary research interests include better understanding the development of substance use disorders in adolescents, the interaction between substance use problems and mental health disorders, and how to effectively treat comorbid disorders. He is particularly interested in better understanding the biology of how cannabis use affects the developing adolescent. Dr. Hinckley and his wife are foster parents, adding to his understanding and appreciation of how substance use affects teenagers and their families. Dr. Hinckley is the recipient of multiple awards, including the National Institute on Drug Abuse and American Academy of Child and Adolescent Psychiatry Resident Training Award in Substance Use Disorders and is currently conducting research as a recipient of the AACAP Physician Scientist Program in Substance Use K12 Career Development Award. He is also co-investigator of a NIDA-funded R01 comparing two therapeutic interventions for adolescents with co-occurring PTSD and substance use problems. Outside of professional responsibilities, Dr. Hinckley is an avid choral musician, wildlife photographer, dog breeder and trainer, and bibliophile.
Past Sessions in this Series:
Advances in Therapeutic Neuromodulation - January 26
Guest Speakers: Jeffrey I. Bennett, MD, LFAPA and Philip G. Janicak, MD
CLICK HERE for the Recording
Back to the Future: Psychedelics in Psychiatry - February 23
Guest Speaker: Fernando Espi Forcen, MD, PhD
CLICK HERE for the Recording
TAAR1: Science Behind a Potential New TAARget for Schizophrenia - March 30
Guest Speaker: LaGenia Bailey, PharmD
CLICK HERE for the Recording
This Event is Sponsored by:
